Aptose Biosciences (APTO) PT Lowered to $7 at Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren lowered the price target on Aptose Biosciences (NASDAQ: APTO) to $7.00 (from $12.00) noting ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
